Tisch MS News

MS Patients Continue to Gain Function and Show Improvement With the International Society for Stem Cell Research’s Annual Meeting as his backdrop, Dr. Saud A. Sadiq delivered more promising results from Tisch MS Research Center of New York’s (Tisch MSRCNY) FDA-approved Phase I stem cell trial. The...

June 29, 2015

More

Congratulations to Dr. Saud A. Sadiq who has been recognized in Castle Connolly's " America's Top Doctors " 14th ed. and "Top Doctors: New York Metro Area" 18th ed. The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of...

January 30, 2015

More

Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial For Patients with Multiple Sclerosis New York, NY - April 23, 2015 - Tisch MS Research Center of New York (Tisch MSRCNY) today announced encouraging preliminary results from its FDA-approved Phase I...

April 22, 2015

More

We are currently the only center in the United States that is conducting an FDA approved clinical trial using stem cells in patients with MS. The goal of the Phase I trial is to determine whether or not the therapy is safe and effective. We hope that this will lead to additional future trials and...

March 30, 2015

More

On Friday, November 20th, at the International Conference on Cell-Based Therapies for Multiple Sclerosis in Lisbon, Portugal, Dr. Sadiq presented the most recent data about our FDA-approved Phase I stem cell trial. Peers from around the world came together to discuss the latest innovations in cell-...

November 23, 2015

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Look for the IFF Building on the North side of 57th Street across from the CBS building

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.